Sandostatin and Ecchymosis - a phase IV clinical study of FDA data
Summary:
Ecchymosis is reported as a side effect among people who take Sandostatin (octreotide acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Indigestion.
The phase IV clinical study analyzes which people have Ecchymosis when taking Sandostatin. It is created by eHealthMe based on reports of 46,692 people who have side effects when taking Sandostatin from the FDA, and is updated regularly.
What is Sandostatin?
Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 46,793 Sandostatin users. Check the latest studies of Sandostatin.
What is Ecchymosis?
Ecchymosis (a discoloration of the skin resulting from bleeding underneath) is found to be associated with 1,014 drugs and 1,085 conditions by eHealthMe. Check the latest studies of Ecchymosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
46,692 people reported to have side effects when taking Sandostatin.
Among them, 80 people (0.17%) have Ecchymosis.

Among these 80 people:
How long have people been on Sandostatin when they have Ecchymosis? *
- < 1 month: 60 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 20 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 20 %
- 10+ years: 0.0 %
What is the gender of people who have Ecchymosis when taking Sandostatin? *
- female: 77.22 %
- male: 22.78 %
What is the age of people who have Ecchymosis when taking Sandostatin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 33.33 %
What are other drugs people take besides Sandostatin? *
- Pantoprazole: 27 people, 33.75%
- Sulfatrim: 24 people, 30.00%
- Dexilant: 24 people, 30.00%
- Magnesium: 21 people, 26.25%
- Afinitor: 15 people, 18.75%
- Synthroid: 14 people, 17.50%
- Vitamin D: 13 people, 16.25%
- Codeine: 12 people, 15.00%
- Morphine: 11 people, 13.75%
- Vitamin B12: 8 people, 10.00%
What are other side effects people have besides Ecchymosis? *
- Pain: 56 people, 70.00%
- Nausea (feeling of having an urge to vomit): 49 people, 61.25%
- Stress And Anxiety: 48 people, 60.00%
- Diarrhea: 48 people, 60.00%
- Hypotension (abnormally low blood pressure): 47 people, 58.75%
- Fatigue (feeling of tiredness): 46 people, 57.50%
- Nausea And Vomiting: 45 people, 56.25%
- Headache (pain in head): 44 people, 55.00%
- Injection Site Pain: 41 people, 51.25%
- Back Pain: 40 people, 50.00%
What are the existing conditions these people have? *
- Indigestion: 11 people, 13.75%
- Neuroendocrine Tumor: 10 people, 12.50%
- Anaemia (lack of blood): 8 people, 10.00%
- Angiodysplasia (small vascular malformation of the gut): 7 people, 8.75%
- Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 6 people, 7.50%
- Nausea (feeling of having an urge to vomit): 5 people, 6.25%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 5.00%
- Diarrhea: 4 people, 5.00%
- Insulinoma (tumour of the pancreas that is derived from beta cells and secretes insulin): 4 people, 5.00%
- Diabetes: 3 people, 3.75%
* Approximation only. Some reports may have incomplete information.
Do you take Sandostatin and have Ecchymosis?
- Check whether Ecchymosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sandostatin:
- Sandostatin (46,793 reports)
Ecchymosis treatments and more:
- Ecchymosis (13,357 reports)
How severe was Ecchymosis and when was it recovered:
Expand to all the drugs that have ingredients of octreotide acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sandostatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Ecchymosis:
- Ecchymosis (1,014 drugs)
Browse all the conditions that are associated with Ecchymosis:
- Ecchymosis (1,085 conditions)
Related publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin) and Sandostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Allegra and Senna - a second ago
- Could Melatonin cause Pyroglutamate Increased? - 6 seconds ago
- Could Rubraca cause Pulmonary Oedema? - 7 seconds ago
- Could Roxicet cause Death? - 11 seconds ago
- Could Liver Oil cause Agranulocytosis? - 13 seconds ago
- Could Rosuvastatin Calcium cause Belching? - 21 seconds ago
- Lo/Ovral and Unintended Pregnancy for Girls aged 10-19 - 22 seconds ago
- Biktarvy and Losartan Potassium drug interactions for men aged 50-59 - 26 seconds ago
- Could Lansoprazole cause Genital Rash? - 33 seconds ago
- Could Zofran cause Acute Myocardial Infarction? - 36 seconds ago